-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Maravai Lifesciences Holdings, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2020 to Q2 2025.
- Maravai Lifesciences Holdings, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2025 was 144M shares, a 6.18% increase year-over-year.
- Maravai Lifesciences Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 138M shares, a 4.54% increase from 2023.
- Maravai Lifesciences Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 132M shares, a 48.3% decline from 2022.
- Maravai Lifesciences Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 255M shares, a 0.96% decline from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)